Payload technology to optimize radioimmunotherapies - A novel treatment option for cancer patients resistant to chemotherapy

Research unit

INNOSUISSE

Project number

120.375 IP-LS

Project title

Payload technology to improve radioimmunotherapies - A novel treatment option for cancer patients resistant to chemotherapy

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	We develop a novel antibody-radionuclide conjugate (ARC), L1CAM-Tb-161, offering a new therapeutic window for patients with resistance to chemotherapy. Based on our non-toxic polymer-payload technology we conjugate common & novel isotopes to an antibody targeting the human cell adhesion molecule L1.